EGb-761
From Wikipedia, the free encyclopedia
Trade namesGingogink; Tebonin; Tramisal
Other namesGBE 761; Ginkgo biloba special extract; EGb761
| Clinical data | |
|---|---|
| Trade names | Gingogink; Tebonin; Tramisal |
| Other names | GBE 761; Ginkgo biloba special extract; EGb761 |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | Not fully established |
| Metabolism | Not fully established |
| Identifiers | |
| CAS Number | |
EGb-761 (also written EGb 761, branded Gingogink, Tebonin, Tramisal) is a standardised extract of the leaves of the tree Ginkgo biloba, containing flavonoid glycosides and terpene lactones, and used in some countries for symptoms such as cognitive decline, peripheral circulatory disorders, tinnitus and vertigo.[1]